We are live on ! Find out more
YCM

Yiheng Capital Management Portfolio holdings

AUM $231M
1-Year Est. Return 29.07%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+29.07%
3 Year Est. Return
+63.69%
5 Year Est. Return
+56.64%
10 Year Est. Return
+851.36%
AUM
$2.53B
AUM Growth
+$269M
Cap. Flow
+$482M
Cap. Flow %
19.07%
Top 10 Hldgs %
82.75%
Holding
37
New
4
Increased
7
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
RBLX icon
Roblox
RBLX
+$38.5M
2
KROS icon
Keros Therapeutics
KROS
+$28M
3
INDI icon
indie Semiconductor
INDI
+$21.1M
4
VRDN icon
Viridian Therapeutics
VRDN
+$8.51M
5
JD icon
JD.com
JD
+$5.75M

Sector Composition

Rank Sector Weight
1 Communication Services 12.45%
2 Consumer Discretionary 9.02%
3 Healthcare 8.08%
4 Consumer Staples 5.97%
5 Industrials 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JD icon
1
CALL
JD.com
JD
$41.4B
$823M 32.56%
18,761,600
+7,284,300
+63% +$376M
BILI icon
2
CALL
Bilibili
BILI
$7.83B
$349M 13.79%
14,839,100
+4,320,100
+41% +$103M
BILI icon
3
Bilibili
BILI
$7.83B
$265M 10.47%
11,270,198
-180,819
-2% -$4.3M
HTHT icon
4
Huazhu Hotels Group
HTHT
$12.8B
$136M 5.39%
2,783,620
EDU icon
5
New Oriental
EDU
$7.91B
$133M 5.26%
3,442,666
-499,706
-13% -$20.2M
NOAH
6
Noah Holdings
NOAH
$613M
$104M 4.12%
6,719,722
JD icon
7
JD.com
JD
$41.4B
$86.5M 3.42%
1,971,740
+111,300
+6% +$5.75M
TDG icon
8
TransDigm Group
TDG
$67.6B
$74.7M 2.95%
101,312
-6,300
-6% -$4.5M
HOLI
9
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$68.7M 2.72%
3,963,836
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$52.2M 2.06%
2,143,497
-1,469,757
-41% -$32.2M
PENG
11
Penguin Solutions Inc
PENG
$2.72B
$50.9M 2.01%
2,953,992
EDU icon
12
CALL
New Oriental
EDU
$7.91B
$46.7M 1.85%
+1,210,200
New +$48.9M
RBLX icon
13
Roblox
RBLX
$39B
$45.4M 1.79%
+1,008,274
New +$38.5M
SABR icon
14
Sabre
SABR
$684M
$44.7M 1.77%
10,421,742
AKRO
15
DELISTED
Akero Therapeutics
AKRO
$43.1M 1.7%
1,125,791
-343,114
-23% -$15.3M
VRDN icon
16
Viridian Therapeutics
VRDN
$2.11B
$31.3M 1.24%
1,228,534
+265,278
+28% +$8.51M
INDI icon
17
indie Semiconductor
INDI
$797M
$24.9M 0.98%
+2,360,221
New +$21.1M
KROS icon
18
Keros Therapeutics
KROS
$210M
$23.7M 0.94%
+554,151
New +$28M
DNLI icon
19
Denali Therapeutics
DNLI
$3.66B
$23.4M 0.92%
1,014,684
ACMR icon
20
CALL
ACM Research
ACMR
$5.82B
$19.4M 0.77%
1,654,700
+996,400
+151% +$11.5M
TAL icon
21
TAL Education Group
TAL
$5.76B
$18.1M 0.71%
2,818,300
+765,900
+37% +$5.51M
BEAM icon
22
Beam Therapeutics
BEAM
$2.74B
$14.2M 0.56%
463,800
HIMX
23
Himax Technologies
HIMX
$2.23B
$9.64M 0.38%
1,185,814
-3,941,902
-77% -$30.4M
IVA
24
Inventiva
IVA
$1.06B
$9.63M 0.38%
2,644,926
GBIO
25
DELISTED
Generation Bio
GBIO
$6.89M 0.27%
160,177
+41,547
+35% +$2.01M

Similar funds

Yiheng Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Yiheng Capital Management held 37 positions worth $2.53B, up 12% from $2.26B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Yiheng Capital Management deployed $482M of net new capital in Q1 2023, opening 4 new positions and adding to 7 existing holdings. Its largest new stake was Roblox: 1,008,274 shares worth $45.4M.

By sector, the portfolio is most concentrated in Communication Services at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was IVERIC bio, Inc. Common Stock, an estimated $32.2M trimmed.

  • Yiheng Capital Management's largest Q1 2023 buy was Roblox: 1,008,274 shares worth $45.4M.
  • Yiheng Capital Management added most to Viridian Therapeutics in Q1 2023, an estimated $8.51M increase.
  • Yiheng Capital Management's biggest Q1 2023 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $32.2M.
  • Yiheng Capital Management's ten largest holdings make up 83% of its $2.53B portfolio in Q1 2023.
  • Yiheng Capital Management opened 4 new positions and closed 2 in Q1 2023.
  • Yiheng Capital Management's portfolio value rose 12% quarter-over-quarter to $2.53B.

Based on Yiheng Capital Management's 13F filing for Q1 2023, filed 15 May 2023.